Glenmark Pharmaceuticals
GLENMARK.NS
#3127
Rank
$3.62 B
Marketcap
$12.86
Share price
3.52%
Change (1 day)
104.13%
Change (1 year)

Market capitalization of Glenmark Pharmaceuticals (GLENMARK.NS)

Market cap: $3.62 Billion

As of April 2024 Glenmark Pharmaceuticals has a market cap of $3.62 Billion. This makes Glenmark Pharmaceuticals the world's 3127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Glenmark Pharmaceuticals from 2005 to 2024

End of year Market Cap

Year Market cap Change
2024$3.62 B25.1%
2023$2.90 B100.49%
2022$1.44 B-27.78%
2021$2.00 B5.25%
2020$1.90 B38.39%
2019$1.37 B-50.78%
2018$2.79 B6.58%
2017$2.62 B-28.98%
2016$3.69 B-5.74%
2015$3.91 B18.74%
2014$3.29 B40.88%
2013$2.34 B-10.31%
2012$2.60 B76.06%
2011$1.48 B-32.21%
2010$2.18 B46.83%
2009$1.48 B-2.8%
2008$1.53 B-57.98%
2007$3.64 B348.88%
2006$0.81 B96.44%
2005$0.41 B

End of Day market cap according to different sources

On Apr 24th, 2024 the market cap of Glenmark Pharmaceuticals was reported to be:

$3.62 Billion
by Yahoo Finance info icon info icon
$3.62 Billion
by CompaniesMarketCap info icon info icon